Bindingsmolekyler, der er i stand til at neutralisere rabiesvirus, og anvendelser deraf

摘要

A pharmaceutical composition including at least two rabies virus neutralizing binding molecules that are capable of reacting with different, non-competing epitopes of the rabies virus. The first rabies virus neutralizing binding molecule is capable of reacting with an epitope located in antigenic site I of the rabies virus G protein. The second rabies virus neutralizing binding molecule is capable of reacting with an epitope located in antigenic site III of the rabies virus G protein.